Novartis Oncology

Reimagining medicine at Novartis Oncology

Bold in our pursuit to reimagine medicine

Novartis Oncology is inspired by patients to revolutionize the research, development and manufacturing of innovative, high quality medicines that help to improve and extend people’s lives.

Novartis at EHA

Novartis is virtually present at the 25th European Hematology Association (EHA) Annual Congress.


Novartis at ASCO

Latest oncology resources and news surrounding Novartis data featured at American Society of Clinical Oncology (ASCO).

Read More

Reimagining cancer in the workplace

Novartis is strongly committed in helping and supporting employees impacted by cancer through the global workplace program Ensemble – Caring for Colleagues.

Learn More

Our scientists are breaking through the barriers to transform cancer care and reimagine medicine.

Learn More

"Cancer is a chapter in history we will rewrite. Novartis is positioned to reimagine cancer and transform the lives of patients around the world."
Susanne Schaffert President, Novartis Oncology
Novartis Oncology Product Portfolio and Global Clinical Pipeline
Recent Jobs in Oncology

When science and passion connect, innovation happens. Join us.

Awards and Recognition

Novartis is honored to receive numerous awards for progress in research and development, our working environment, and our corporate responsibility activities.

  • Woman scientist wearing protective clothes

    Fortune's Most Admired Pharmaceutical Companies 2020

    Novartis ranks #4 in Fortune Magazine’s Most Admired Companies Pharmaceutical Industry list.